Trial Profile
Phase I study of CSTI-100 in overweight subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 May 2018
Price :
$35
*
At a glance
- Drugs CSTI-100 (Primary)
- Indications Non-alcoholic steatohepatitis
- Focus Adverse reactions
- 03 May 2018 New trial record
- 25 Apr 2018 According to a ConSynance media release, the company presented data on this phase I study at NASH Summit 2018.